Patents by Inventor Christopher L. Sutton

Christopher L. Sutton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
    Patent number: 7993867
    Abstract: The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence or IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: August 9, 2011
    Assignees: Cedars-Sinai Medical Center, The Regents of the University of California
    Inventors: Stephan R. Targan, Jonathan Braun, Christopher L. Sutton
  • Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
    Patent number: 7993865
    Abstract: The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence or IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: August 9, 2011
    Assignees: Cedars-Sinai Medical Center, The Regents of the University of California
    Inventors: Stephan R. Targan, Jonathan Braun, Christopher L. Sutton
  • Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
    Patent number: 7993866
    Abstract: The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence or IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: August 9, 2011
    Assignees: Cedars-Sinai Medical Center, The Regents of the University of California
    Inventors: Stephan R. Targan, Jonathan Braun, Christopher L. Sutton
  • DIAGNOSIS, PREVENTION AND TREATMENT OF CROHN'S DISEASE USING THE OMPC ANTIGEN
    Publication number: 20090221006
    Abstract: The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence or IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
    Type: Application
    Filed: January 12, 2009
    Publication date: September 3, 2009
    Applicants: Cedars-Sinai Medical, The Regents of the University of California
    Inventors: Stephan R. Targan, Jonathan Braun, Christopher L. Sutton
  • DIAGNOSIS, PREVENTION AND TREATMENT OF CROHN'S DISEASE USING THE OMPC ANTIGEN
    Publication number: 20090221007
    Abstract: The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence or IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
    Type: Application
    Filed: January 12, 2009
    Publication date: September 3, 2009
    Applicants: Cedars-Sinai Medical Center, The Regents of the University of California
    Inventors: Stephan R. Targan, Jonathan Braun, Christopher L. Sutton
  • Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
    Patent number: 7138237
    Abstract: The present invention provides a method of diagnosing Crohn's disease in a subject by determining the presence or absence of IgA anti-OmpC antibodies in the subject, where the presence of the IgA anti-OmpC antibodies indicates that the subject has Crohn's disease.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: November 21, 2006
    Assignees: Cedars-Sinai Medical Center, The Regents of the University of California
    Inventors: Stephan R. Targan, Jonathan Braun, Christopher L. Sutton
  • IBD-associated microbial nucleic acid molecules
    Publication number: 20020115848
    Abstract: The present invention provides nucleic acid and amino acid sequence of the novel I-1 and I-2 polypeptides, which are associated with human inflammatory bowel disease (IBD). Methods of diagnosing and treating inflammatory bowel disease using the IBD-associated I-1 and I-2 antigens also are provided.
    Type: Application
    Filed: September 27, 2001
    Publication date: August 22, 2002
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Jonathan Braun, Christopher L. Sutton